Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	41.18B +45.8%
Revenue (ttm)	6.93B +16.6%
Net Income	1.11B +11.7%
EPS	3.11 +10.0%
Shares Out	359.72M
PE Ratio	37.78
Forward PE	28.69
Dividend	1.30 (1.11%)
Ex-Dividend Date	Jun 26, 2025

Volume	6,991,784
Open	126.14
Previous Close	117.62
Day's Range	114.73 - 126.14
52-Week Range	81.91 - 132.98
Beta	0.16
Analysts	Buy
Price Target	143.89 (+22.54%)
Earnings Date	Aug 27, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in ke...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 10,617
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2025, SHE:002821's revenue was 6.67 billion, an increase of 14.91% compared to the previous year's 5.80 billion. Earnings were 1.13 billion, an increase of 19.35%.